JP2005500354A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500354A5 JP2005500354A5 JP2003517052A JP2003517052A JP2005500354A5 JP 2005500354 A5 JP2005500354 A5 JP 2005500354A5 JP 2003517052 A JP2003517052 A JP 2003517052A JP 2003517052 A JP2003517052 A JP 2003517052A JP 2005500354 A5 JP2005500354 A5 JP 2005500354A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- treatment
- disease
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- -1 3,5-bis-trifluoromethyl-phenyl Chemical group 0.000 claims 3
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 claims 3
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 3
- 206010047700 Vomiting Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000008673 vomiting Effects 0.000 claims 3
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000012425 OXONE® Substances 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 208000012545 Psychophysiologic disease Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 201000003152 motion sickness Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229960002715 nicotine Drugs 0.000 claims 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 1
- 229940127240 opiate Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01118412 | 2001-07-31 | ||
| EP01118412.4 | 2001-07-31 | ||
| PCT/EP2002/008311 WO2003011860A2 (en) | 2001-07-31 | 2002-07-26 | 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005500354A JP2005500354A (ja) | 2005-01-06 |
| JP2005500354A5 true JP2005500354A5 (https=) | 2005-11-17 |
| JP4700908B2 JP4700908B2 (ja) | 2011-06-15 |
Family
ID=8178193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517052A Expired - Fee Related JP4700908B2 (ja) | 2001-07-31 | 2002-07-26 | ２−（３，５−ビス−トリフルオロメチル−フェニル）−Ｎ−〔６−（１，１−ジオキソ−１λ６−チオモルホリン−４−イル）−４−（２−メチル又は４−フルオロ−２−メチル置換）フェニル−ピリジン−３−イル〕−Ｎ−メチル−イソブチルアミド |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6849624B2 (https=) |
| EP (1) | EP1414525B1 (https=) |
| JP (1) | JP4700908B2 (https=) |
| KR (1) | KR100577101B1 (https=) |
| CN (1) | CN1289497C (https=) |
| AR (1) | AR034921A1 (https=) |
| AT (1) | ATE430600T1 (https=) |
| BR (1) | BR0211523A (https=) |
| CA (1) | CA2452502C (https=) |
| DE (1) | DE60232246D1 (https=) |
| EA (1) | EA006238B1 (https=) |
| EC (1) | ECSP044963A (https=) |
| ES (1) | ES2324209T3 (https=) |
| GT (1) | GT200200159A (https=) |
| HR (1) | HRP20040039A2 (https=) |
| HU (1) | HUP0400398A3 (https=) |
| MA (1) | MA27055A1 (https=) |
| MX (1) | MXPA04000917A (https=) |
| MY (1) | MY128464A (https=) |
| NO (1) | NO20040404L (https=) |
| NZ (1) | NZ530579A (https=) |
| PA (1) | PA8551601A1 (https=) |
| PE (1) | PE20030276A1 (https=) |
| PL (1) | PL366986A1 (https=) |
| UA (1) | UA77685C2 (https=) |
| UY (1) | UY27403A1 (https=) |
| WO (1) | WO2003011860A2 (https=) |
| YU (1) | YU2704A (https=) |
| ZA (1) | ZA200400652B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE323531T1 (de) * | 2001-04-23 | 2006-05-15 | Hoffmann La Roche | Verwendung von nk-1-rezeptorantagonisten gegen benigne prostatahyperplasie |
| SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| ES2285233T3 (es) | 2002-12-20 | 2007-11-16 | Niconovum Ab | Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable. |
| ATE366576T1 (de) * | 2003-01-31 | 2007-08-15 | Hoffmann La Roche | Neue kristallmodifikation von 2-(3,5-bis- trifluormethyl-phenyl)-n-6-(1,1-dioxo-1lamda-6- |
| CN1984891B (zh) | 2004-07-06 | 2012-08-08 | 弗·哈夫曼-拉罗切有限公司 | 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法 |
| ES2329827T3 (es) * | 2005-02-22 | 2009-12-01 | F. Hoffmann-La Roche Ag | Antagonistas de nk1. |
| JP2008531509A (ja) | 2005-02-25 | 2008-08-14 | エフ．ホフマン−ラ ロシュ アーゲー | 医薬品成分の改良された分散性を有する錠剤 |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| GB0808747D0 (en) | 2008-05-14 | 2008-06-18 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
| US10383894B2 (en) * | 2010-03-17 | 2019-08-20 | Lutran Industries, Inc. | Human medicinal treatment using salt of peroxymonosulfuric acid |
| RU2673084C2 (ru) | 2013-11-08 | 2018-11-22 | Киссеи Фармасьютикал Ко., Лтд. | Производное карбоксиметилпиперидина |
| TWI649307B (zh) | 2014-05-07 | 2019-02-01 | 日商橘生藥品工業股份有限公司 | Cyclohexylpyridine derivative |
| CA2978736C (en) | 2015-03-04 | 2023-11-07 | Vanda Pharmaceuticals Inc. | Dosing regimen of tradipitant |
| CN112218636B (zh) * | 2018-06-08 | 2025-05-06 | 万达制药公司 | 使用川地匹坦进行治疗的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6435115A (en) * | 1987-07-31 | 1989-02-06 | Nippon Seiko Kk | Bearing device |
| IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
| CA2178219C (en) | 1993-12-29 | 2005-03-22 | Raymond Baker | Substituted morpholine derivatives and their use as therapeutic agents |
| IL112778A0 (en) | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
| EP1394150B1 (en) | 1999-02-24 | 2011-01-19 | F. Hoffmann-La Roche AG | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| ATE323531T1 (de) * | 2001-04-23 | 2006-05-15 | Hoffmann La Roche | Verwendung von nk-1-rezeptorantagonisten gegen benigne prostatahyperplasie |
-
2002
- 2002-07-17 US US10/196,795 patent/US6849624B2/en not_active Expired - Fee Related
- 2002-07-25 PE PE2002000667A patent/PE20030276A1/es not_active Application Discontinuation
- 2002-07-26 PL PL02366986A patent/PL366986A1/xx not_active Application Discontinuation
- 2002-07-26 MX MXPA04000917A patent/MXPA04000917A/es active IP Right Grant
- 2002-07-26 BR BR0211523-9A patent/BR0211523A/pt not_active Application Discontinuation
- 2002-07-26 HR HR20040039A patent/HRP20040039A2/hr not_active Application Discontinuation
- 2002-07-26 ES ES02791471T patent/ES2324209T3/es not_active Expired - Lifetime
- 2002-07-26 PA PA20028551601A patent/PA8551601A1/es unknown
- 2002-07-26 JP JP2003517052A patent/JP4700908B2/ja not_active Expired - Fee Related
- 2002-07-26 CN CNB028151100A patent/CN1289497C/zh not_active Expired - Fee Related
- 2002-07-26 HU HU0400398A patent/HUP0400398A3/hu unknown
- 2002-07-26 UA UA2004021462A patent/UA77685C2/uk unknown
- 2002-07-26 WO PCT/EP2002/008311 patent/WO2003011860A2/en not_active Ceased
- 2002-07-26 CA CA2452502A patent/CA2452502C/en not_active Expired - Fee Related
- 2002-07-26 NZ NZ530579A patent/NZ530579A/en unknown
- 2002-07-26 YU YU2704A patent/YU2704A/sh unknown
- 2002-07-26 AT AT02791471T patent/ATE430600T1/de active
- 2002-07-26 EP EP02791471A patent/EP1414525B1/en not_active Expired - Lifetime
- 2002-07-26 KR KR1020047001322A patent/KR100577101B1/ko not_active Expired - Fee Related
- 2002-07-26 DE DE60232246T patent/DE60232246D1/de not_active Expired - Lifetime
- 2002-07-26 EA EA200400109A patent/EA006238B1/ru not_active IP Right Cessation
- 2002-07-29 MY MYPI20022848A patent/MY128464A/en unknown
- 2002-07-29 AR ARP020102847A patent/AR034921A1/es not_active Application Discontinuation
- 2002-07-30 UY UY27403A patent/UY27403A1/es not_active Application Discontinuation
- 2002-07-31 GT GT200200159A patent/GT200200159A/es unknown
-
2004
- 2004-01-27 ZA ZA200400652A patent/ZA200400652B/xx unknown
- 2004-01-29 EC EC2004004963A patent/ECSP044963A/es unknown
- 2004-01-29 NO NO20040404A patent/NO20040404L/no unknown
- 2004-01-30 MA MA27507A patent/MA27055A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005500354A5 (https=) | ||
| JP4742026B2 (ja) | ロフルミラストの新規の製造方法 | |
| JP4053877B2 (ja) | ４−フェニル−ピリジン誘導体 | |
| CA2452502A1 (en) | 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide | |
| JP2005533860A5 (https=) | ||
| JP2021501151A5 (https=) | ||
| JP2004504400A5 (https=) | ||
| CA2516370A1 (en) | A process of preparing imatinib and imatinib prepared thereby | |
| CA2438991A1 (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| JP6642914B2 (ja) | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 | |
| JP2004534816A5 (https=) | ||
| JP2017533968A5 (https=) | ||
| JP2002537382A (ja) | ３−フェニルピリジン誘導体、およびそのｎｋ−１受容体拮抗薬としての用途 | |
| BG106853A (bg) | Антагонисти на кортикотропин освобождаващ фактор | |
| CY1107411T1 (el) | Θεραπευτικα παραγωγα πιπεραζινης χρησιμα για την αγωγη του πονου | |
| CA2540768A1 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
| JPWO2019160057A5 (https=) | ||
| CA2326529A1 (en) | 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide | |
| JP2009500292A (ja) | ４−アリル−ニコチンアミド誘導体の製造方法 | |
| JP2007532637A5 (https=) | ||
| JP2004504308A5 (https=) | ||
| NZ547523A (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
| JP2005513004A5 (https=) | ||
| JP2003529597A5 (https=) | ||
| JPWO2008029924A1 (ja) | 環状アミノアルキルカルボキサミド誘導体 |